Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Cancers|May 13, 2026
T-Cell Clonal Expansion in Peripheral Blood Following Interventional Radiology Procedures for Metastatic Liver CancerChenyang Zhan, Anita Karimi, Leila Haghani, et al.
Current Oncology (Toronto, Ont.)|January 24, 2025
TP53 Mutation Predicts Worse Survival and Earlier Local Progression in Patients with Hepatocellular Carcinoma Treated with Transarterial EmbolizationKen Zhao, Anita Karimi, Luke Kelly, et al.
Cancers|October 29, 2025
Hepatocellular Carcinoma Growth Kinetics and Outcomes After Transarterial Embolization: A Single-Center AnalysisKen Zhao, Harrison Blume, Elena N Petre, et al.
Current Oncology (Toronto, Ont.)|October 27, 2023
Safety and Efficacy of Hepatic Artery Embolization in Heavily Treated Patients with Intrahepatic Cholangiocarcinoma: Analysis of Clinicopathological and Radiographic Parameters Associated with Better Overall SurvivalSara Velayati, Ahmed Elsakka, Ken Zhao, et al.
Journal of Vascular and Interventional Radiology : JVIR|November 7, 2025
Safety and Feasibility of Intra-Arterial Treatment of Pancreatic Cancer Using an Emulsion of Ethiodized Oil plus Bumetanide in an Oncopig ModelHooman Yarmohammadi, Sam Y Son, Aaron W P Maxwell, et al.
American Journal of Obstetrics and Gynecology|July 29, 2015
Magnetic resonance imaging of acute appendicitis in pregnancy: a 5-year multiinstitutional studyLauren M B Burke, Mustafa R Bashir, Frank H Miller, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 10, 2025
Biliary Tract Cancers, Version 2.2025, NCCN Clinical Practice Guidelines In OncologyAl B Benson, Michael I D'Angelica, Thomas Abrams, et al.
Research Square|September 15, 2025
Pembrolizumab and Olaparib (POLAR) Maintenance Therapy in Metastatic Pancreatic Cancer With or Without Homologous Repair Deficiency: A Biomarker Selected Phase II TrialWungki Park, Catherine O'Connor, Joanne Chou, et al.
Nature Medicine|March 26, 2026
Pembrolizumab and olaparib in homologous-recombination-deficient metastatic pancreatic cancer: the phase 2 POLAR trialWungki Park, Catherine A O'Connor, Joanne F Chou, et al.
Pageof 5